Diagnosing hereditary colorectal cancer

Area of Science:

• Oncology
• Genetics
• Cancer Research

Background:

• Colorectal cancer (CRC) remains a significant cause of cancer mortality, despite advances in treatment and screening.
• While hereditary CRC syndromes are recognized, they explain only a fraction of familial cases, highlighting a gap in understanding genetic predisposition.
• Effective identification of individuals with hereditary CRC is vital for targeted prevention and management strategies.

Purpose of the Study:

• To explore the genetic underpinnings of colorectal cancer predisposition beyond known high-penetrance syndromes.
• To assess the potential clinical utility of novel genetic variants identified through genome-wide association studies (GWAS) for CRC risk stratification.

Main Methods:

• Review of current literature on colorectal cancer treatment, screening, and hereditary syndromes.
• Analysis of findings from recent genome-wide association studies (GWAS) identifying genetic variants associated with CRC risk.
• Evaluation of the current limitations and future potential for clinical application of genetic risk variants in CRC.

Main Results:

• Most patients with metastatic colorectal cancer (CRC) still succumb to the disease, and early-stage patients often require surgery and chemotherapy.
• Known high-penetrance genetic syndromes account for a minority of familial CRC cases.
• Genome-wide association studies have identified novel genetic variants linked to modest increases in CRC risk, suggesting new pathways in carcinogenesis.

Conclusions:

• Despite improved survival, CRC remains a major health concern, necessitating better strategies for high-risk individuals.
• The genetic basis of familial CRC is not fully explained by known high-penetrance syndromes.
• Current genetic risk variants offer insights into CRC development but have limited clinical use for risk stratification at present.